Clinical trialNCT05283486CompletedPhase 2Interventional

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

SponsorTNF Pharmaceuticals, Inc.Enrollment40AgingFrailtySarcopenia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study will be conducted to investigate the efficacy, tolerability and pharmacokinetics of MYMD1 in participants with chronic inflammation associated with sarcopenia/frailty, a condition linked to elevated levels of proinflammatory cytokines.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Jeremy Walston, MD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗
Leonard Dunn, MD
Clinical Research of West Florida
Principal Investigator
clinicaltrials.gov ↗
Lon Lynn, DO
Clinical Research of West Florida
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clinical Research of West Florida, Inc
Clearwater, Florida, United States
Clinical Research of West Florida
Tampa, Florida, United States
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MYMD-1 1050mgMYMD-1 600MGMYMD-1 750mgMYMD-1 900mgPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Feb 2022
Primary completion: 7 Jun 2023
Completion: 7 Jun 2023
Last update posted: 30 Oct 2023
Registered enrollment: 40
Registry id: NCT05283486

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.